MedTrace Logo

Systems Addressing Frail Elders (SAFE) Care Implementation

NCT02854826 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 330

Last updated 2018-08-31

No results posted yet for this study

Summary

Systems Addressing Frail Elders (SAFE) Care is a nurse-led interprofessional team model to rapidly identify and provide safe and effective inpatient care to high risk older adults and help support their successful transition back to the community. Developed and demonstrated to be effective in one hospital - the model is now being disseminated and studied in three additional hospitals (multiple organizational case study).

Conditions

  • Frail Older Adutls

Interventions

OTHER

SAFE Care model of care

SAFE Care Model Site Intervention: 1. Endorse best practices for frail patients; 2. Identify frail patients promptly using multi-dimensional screening and assessments; 3. Employ interprofessional unit-based care team approach to frailty risk reduction during inpatient stay and create post-acute care transitions (PACT) plan recommendations; 4. Develop electronic health record templates for patient-centered interprofessional frailty notes; 5. Communicate PACT plans to primary care providers to promote safe transitions to the ambulatory setting and across the continuum of care. 6. Increase awareness, improve management of frailty, and improve overall health and well-being for adults who are frail or at risk of becoming frail.

Sponsors & Collaborators

  • UniHealth Foundation

    collaborator UNKNOWN

  • Ronald Reagan Medical Center

    collaborator UNKNOWN

  • Huntington Hospital

    collaborator OTHER_GOV

  • Torrance Memorial

    collaborator UNKNOWN

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Lianna Z Ansryan, MSN · Cedars Sinai

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2018-07-27
Completion
2018-07-27

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02854826 on ClinicalTrials.gov